<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01064544</url>
  </required_header>
  <id_info>
    <org_study_id>R-09.37 M / SHINE</org_study_id>
    <nct_id>NCT01064544</nct_id>
  </id_info>
  <brief_title>Study on Hemodialysis: Illumination Effects</brief_title>
  <acronym>SHINE</acronym>
  <official_title>Effects of Light Therapy on Sleep, Melatonin Rhythm and Mood in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meander Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meander Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous research has shown that sleep quality in hemodialysis patients is disturbed. One of
      the possible explanations is an insufficient or disturbed melatonin rhythm. Melatonin rhythm
      is regulated by exposure to light. In this feasibility study, the investigators examine the
      effects of light therapy during dialysis on sleep, melatonin rhythm and mood.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of sleep parameters</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in subjective sleep parameters</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mood</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in melatonin concentrations</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Sleep Problems</condition>
  <arm_group>
    <arm_group_label>Starting with light therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starts with 3 weeks of light therapy, followed by a control period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ending with light therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ends with 3 weeks of light therapy after a control period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>light therapy with the device: EnergyLight</intervention_name>
    <description>2 hr of light therapy during each hemodialysis session</description>
    <arm_group_label>Starting with light therapy</arm_group_label>
    <arm_group_label>Ending with light therapy</arm_group_label>
    <other_name>Philips Energylight</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent

          -  men/women aged 18-85 years

          -  knowledge of the dutch language

          -  hemodialysis patient

          -  subjective sleep problems (Epworth sleepiness score &gt;9)

        Exclusion Criteria:

          -  known major illness, which interferes with patient's participation

          -  use of melatonin/hypnotics

          -  use of photosensitizing medication

          -  jet lag or travel &gt; 1 time zone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Gaillard, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Meander Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Meander Medical Center</name>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2010</study_first_submitted>
  <study_first_submitted_qc>February 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2010</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Department of Clinical Pharmacy</name_title>
    <organization>Meande Medical Center</organization>
  </responsible_party>
  <keyword>Sleep problems</keyword>
  <keyword>melatonin</keyword>
  <keyword>mood</keyword>
  <keyword>Hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

